Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
36 /100
MEDIUM RISK
Score updated Aug 28, 2026

MBX — MBX Biosciences, Inc. Dilution Risk Tracker

Track MBX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MBX — Get alerts when the score changes →

As of August 28, 2026, MBX Biosciences, Inc. (MBX) has a DilutionWatch DilutionScore of 36/100, rated MEDIUM dilution risk. MBX Biosciences, Inc. has a market capitalization of $1.50B, 48.16M shares outstanding, 159 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
0
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for MBX.
🔔 Track MBX — Get forecast alerts →

Market Data

Market Cap$1.50B
Shares Outstanding48.16M
Float29.55M
Cash$418.58M
Debt$555.0K
Short InterestN/A

Institutional Holdings

QoQ: ↑ 14.8% shares (2026Q1 vs prior)
159 institutional holders · 56.40M shares
#1 Frazier Life Sciences Management, L.P. 6.65M shares
#2 ORBIMED ADVISORS LLC 3.64M shares
#3 NEA Management Company, LLC 3.61M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.19M
Days to Cover8.5
% of Float17.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

3 FORM3 2026-03-18
4 INSIDER TRANSACTION 2026-03-16
4 INSIDER TRANSACTION 2026-02-27
8-K 8K EVENT 2026-02-05
4 INSIDER TRANSACTION 2026-02-03
Full SEC filing analysis available with free account

Recent News

No recent news

Factual MBX Dilution Snapshot

MBX Biosciences, Inc. (MBX) has a DilutionScore of 36/100, rated Medium dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track MBX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MBX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — MEDIUM Risk

Other MEDIUM dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for MBX
MBX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.